Category: Tysabri

Sub Q – Tysabri Injection Study – for People With MS

The information found here was obtained from Erin T. A study to evaluate delivery of Natalizumab (Tysabri®) Study Rationale: While…

Stuart Schlossman

THE Multiple Sclerosis Resource Centre (MSRC) Tysabri Diaries

Did you know that if you are a Tysabri® user, you can have your own place to write diary or…

Stuart Schlossman

NFL Player will not let MS slow him down

By Kevin Scarbinsky — The Birmingham News February 28, 2010, Like a lot of football players, Courtney Taylor is waiting…

Stuart Schlossman

Tysabri Will Remain Decision Resources’ Clinical Gold Standard Through 2018 for the Treatment of Secondary Progressive Multiple Sclerosis

Biogen Idec/Elan’s Tysabri Will Remain Decision Resources’ Clinical Gold Standard Through 2018 for the Treatment of Secondary Progressive Multiple Sclerosis…

Stuart Schlossman

An MS patients’ views of his current Drug therapy for Multiple Sclerosis and about Quality of Life

Written By Stuart Schlossman – February 22, 2010 Albeit, I was not confident in having to make the decision to…

Stuart Schlossman

Tysabri now linked to (35) cases of PML – progressive multifocal leukoencephalopathy

Source: Bloomberg Report Biogen, Elan’s Drug Linked to 35 Brain-Disease Cases (Adds TYSABRI label information in the fifth paragraph, sales…

Stuart Schlossman

Tysabri (Natalizumab): Update of Healthcare Professional Information – “IRIS”

source: FDA.gov Audience: Neurological healthcare professionals, patients [Posted 02/05/2010] FDA notified healthcare professionals and patients that the risk of developing…

Stuart Schlossman

Biogen Plans First Study For Earlier Use Of MS Drug Tysabri

By Thomas Gryta Of DOW JONES NEWSWIRES NEW YORK (Dow Jones) Biogen Idec Inc. (BIIB) is planning the first clinical…

Stuart Schlossman

FDA warns of brain risks with frequent Tysabri use

Yahoo Finance FDA finds connection between brain inflammation and frequent use of Tysabri On Friday February 5, 2010, 12:53 pm…

Stuart Schlossman

Benefits of Tysabri far outweigh risks, European watchdog group says about Multiple Sclerosis drug

Tysabri is given by infusion NMMS January 26, 9:43 PMMultiple Sclerosis ExaminerMike Szymanski A drug watchdog group in Europe has…

Stuart Schlossman

Categories

Latest Blog Posts